Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.

Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.

CONTEXT: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, anovulation, and susceptibility to the metabolic syndrome. Altered peripheral cortisol metabolism has been reported in PCOS, but also in simple obesity. OBJECTIVE: The aim of the study was to describe cortisol metabolis...

Full description

Bibliographic Details
Main Authors:	Vassiliadi, D, Barber, T, Hughes, B, McCarthy, M, Wass, J, Franks, S, Nightingale, P, Tomlinson, J, Arlt, W, Stewart, P
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Obesity and polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2006)

Metabolic syndrome in polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2007)

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2007)

Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.
by: Draper, N, et al.
Published: (2006)

Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.
by: Joharatnam, J, et al.
Published: (2011)

Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
by: Franks, S, et al.
Published: (2006)

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2008)

Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2008)

Androgenemic Phenotype Predicts Metabolic Disease and Androgen Burden in Polycystic Ovary Syndrome
by: O'Reilly, M, et al.
Published: (2013)

Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging.
by: Barber, T, et al.
Published: (2010)

Association of insulin gene VNTR polymorphism with polycystic ovary syndrome - Reply
by: Bennett, S, et al.
Published: (1997)

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
by: O'Reilly, M, et al.
Published: (2014)

Urinary Glucocorticoid Metabolite Excretion is Associated with Insulin Resistance Independent of BMI in Patients with Polycystic Ovary Syndrome
by: O'Reilly, M, et al.
Published: (2012)

Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2008)

AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome
by: O'Reilly, M, et al.
Published: (2017)

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.
by: Waterworth, D, et al.
Published: (1997)

Secondary forms of polycystic ovary syndrome.
by: Kaltsas, G, et al.
Published: (2004)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
by: Kaltsas, G, et al.
Published: (2000)

Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.
by: Franks, S, et al.
Published: (2008)

BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: a case-control study
by: Louwers, Y, et al.
Published: (2014)

Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms.
by: Laitinen, J, et al.
Published: (2003)

Sexual dysfunction in patients with polycystic ovary syndrome in Malaysia
by: Dashti, Sareh, et al.
Published: (2016)

Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition.
by: Barber, T, et al.
Published: (2008)

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis
by: Wojciechowski, P, et al.
Published: (2012)

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis.
by: Wojciechowski, P, et al.
Published: (2012)

Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome.
by: Haddad, L, et al.
Published: (2002)

Erratum to: Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis
by: Wojciechowski, P, et al.
Published: (2012)

The efficacy of metformin and exenatide in Polycystic Ovary Syndrome (PCOS) patients
by: Kesavan, Sanggeeta, et al.
Published: (2023)

Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels.
by: Barber, T, et al.
Published: (2007)

Familial polycystic ovaries: a genetic disease?
by: Hague, WM, et al.
Published: (1988)

Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS.
by: Barber, T, et al.
Published: (2007)

Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?
by: Sverrisdóttir, Y, et al.
Published: (2008)

Mission PCOSsible: a campaign to raise awareness of polycystic ovary syndrome in Singapore
by: Chua, Cerise Wan Ni, et al.
Published: (2024)

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis (vol 55, pg 2636, 2012)
by: Wojciechowski, P, et al.
Published: (2012)

Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement.
by: Chortis, V, et al.
Published: (2013)

Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.
by: Taponen, S, et al.
Published: (2004)

Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins
by: Censin, JC, et al.
Published: (2021)

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
by: Tata, B, et al.
Published: (2018)

Kelulut honey regulates sex steroid receptors in a polycystic ovary syndrome rat model
by: Datu Agasi Mohd Kamal, et al.
Published: (2022)

Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin
by: Anbar, H, et al.
Published: (2023)